Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Roden

Showing results (411-420 of 593) with videos related to

Pageof 60
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2020
Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome-Wide Association Study and Inverse Variance-Weighted Meta-AnalysisVivian K Kawai, Mingjian Shi, Qiping Feng, et al.
JAMA Cardiology|October 13, 2016
Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical RecordsMatthew J Kolek, Amy J Graves, Meng Xu, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 UpdateCraig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
Thrombosis and Haemostasis|December 16, 2014
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical recordJason H Karnes, Robert M Cronin, Jerome Rollin, et al.
The Journal of Clinical Investigation|May 10, 2008
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humansHiroshi Watanabe, Tamara T Koopmann, Solena Le Scouarnec, et al.
Journal of the American College of Cardiology|February 25, 2014
Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndromePeter Weeke, Jonathan D Mosley, David Hanna, et al.
JAMA Cardiology|September 8, 2021
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia GenesZachary T Yoneda, Katherine C Anderson, Joseph A Quintana, et al.
Blood Advances|May 9, 2022
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopeniaJason B Giles, Heidi E Steiner, Jerome Rollin, et al.
Circulation. Arrhythmia and Electrophysiology|January 17, 2012
A connexin40 mutation associated with a malignant variant of progressive familial heart block type INaomasa Makita, Akiko Seki, Naokata Sumitomo, et al.
Pharmacogenomics|February 15, 2012
Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health recordAndrea H Ramirez, Yaping Shi, Jonathan S Schildcrout, et al.
Pageof 60

Showing results (411-420 of 593) with videos related to

Sort By:
Pageof 60
Arthritis & Rheumatology (Hoboken, N.J.)|April 21, 2020
Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome-Wide Association Study and Inverse Variance-Weighted Meta-AnalysisVivian K Kawai, Mingjian Shi, Qiping Feng, et al.
JAMA Cardiology|October 13, 2016
Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical RecordsMatthew J Kolek, Amy J Graves, Meng Xu, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 UpdateCraig R Lee, Jasmine A Luzum, Katrin Sangkuhl, et al.
Thrombosis and Haemostasis|December 16, 2014
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical recordJason H Karnes, Robert M Cronin, Jerome Rollin, et al.
The Journal of Clinical Investigation|May 10, 2008
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humansHiroshi Watanabe, Tamara T Koopmann, Solena Le Scouarnec, et al.
Journal of the American College of Cardiology|February 25, 2014
Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndromePeter Weeke, Jonathan D Mosley, David Hanna, et al.
JAMA Cardiology|September 8, 2021
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia GenesZachary T Yoneda, Katherine C Anderson, Joseph A Quintana, et al.
Blood Advances|May 9, 2022
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopeniaJason B Giles, Heidi E Steiner, Jerome Rollin, et al.
Circulation. Arrhythmia and Electrophysiology|January 17, 2012
A connexin40 mutation associated with a malignant variant of progressive familial heart block type INaomasa Makita, Akiko Seki, Naokata Sumitomo, et al.
Pharmacogenomics|February 15, 2012
Predicting warfarin dosage in European-Americans and African-Americans using DNA samples linked to an electronic health recordAndrea H Ramirez, Yaping Shi, Jonathan S Schildcrout, et al.
Pageof 60